Ultrasound-guided LMBB by Caudal-cranial Approach: Radiographic Comparison of a New Ultrasound-guided Method
Unknown statusNot applicableNCT05930236
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The current standard technique is radiography requiring three uni- or bilateral punctures (transverse-axial plane). The ultrasound technique is also described mainly in this plan but a new "caudal-cranial" ultrasound-guided technique was described by Chang et al in 2018 in which the major axis is used to conduct the needle to the desired area. The investigators would like to confirm that this new technique in a single puncture is also possible under ultrasound.
Study details
- Official title
- Ultrasound-guided Medial Lumbar Bundle Branch Block by Caudal-cranial Approach: Radiographic Comparison of a New Ultrasound-guided Method
- Conditions
- Chronic Low-back Pain
- Lumbar Facet Joint Syndrome
- Interventions
- Diagnostic test: Lumbar medial branch block
- Drug: Lidocain
- Drug: Methylprednisolone
- Drug: Omnipaque
- Sponsor
- Erasme University Hospital
- Start date
- 2023-04-21
- Primary completion
- 2024-06
- Sex
- All
- Age range
- from 20 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * chronic low back pain compatible with facet lumbar syndrome with chronic pain of at least 3 months * who have not responded to conservative treatment after at least 4 weeks * patients without signs of dissociated pain, radiculitis, neurological diseases including stroke and Parkinson's disease, spinal instability or deformities such as scoliosis, ankylosing spondylitis, history of lumbar surgery, fracture or lumbar tumor Exclusion Criteria: * Pregnant or breastfeeding women * Allergy to injected products (Depomedrol or Linisol) * Psychiatric disorders hindering understanding of the protocol * Local or systemic infection * Coagulation disorder * Obese with a BMI\> 35 kg / m²
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05930236